US FDA: Pfizer Covid-19 Vaccine Proves Highly Effective in Children Between 5 to 11 years


According to a statement given by the federal health regulators of the United States. The corona virus vaccines developed by Pfizer for the children between 5 to 11 years of age appears to be highly effective in the prevention of the disease and has also been found to not cause any unexpected safety issues, which has been responsible for giving a big boost to the country in the push for kick-starting the covid-19 vaccinations in the young children.

The US FDA has also shared the analysis of the data submitted by Pfizer a week bore the public meeting for the purpose of deciding whether the novel corona virus vaccine jabs have been ready for around 28 million children in the United States, who are between the age group of 5 to 11 years.

The scientist of the US FDA have also concluded in the analysis that, in around all the possible scenarios, the ability of the Pfizer corona virus vaccine to prevent the hospitalizations and even deaths from the novel corona virus can possibly outweigh any serious side effects of the vaccine.

READ  Covid-19 Cases Increased Again in United States

The authorized shots of the Pfizer novel corona virus vaccine have already been recommended for the children, who are above 12 years of age for the purpose of checking the infections from the highly contagious Delta variant of the novel corona virus, and the review of the US FDA has also re-affirmed the results of Pfizer, which has showed the covid-19 vaccine shot had almost been 91 percent effective at preventing young children from the infection.